Works matching DE "ADENOSINE deaminase deficiency"
Results: 80
Adenosine Deaminase Two and Immunoglobulin M Accurately Differentiate Adult Sneddon's Syndrome of Unknown Cause.
- Published in:
- Cerebrovascular Diseases, 2018, v. 46, n. 5/6, p. 257, doi. 10.1159/000495794
- By:
- Publication type:
- Article
High-yield production of apoplast-directed human adenosine deaminase in transgenic tobacco BY-2 cell suspensions.
- Published in:
- Biotechnology & Applied Biochemistry, 2015, v. 62, n. 1, p. 87, doi. 10.1002/bab.1240
- By:
- Publication type:
- Article
Adenosine regulation of danger signaling.
- Published in:
- Turkish Journal of Immunology, 2016, v. 4, p. 72
- By:
- Publication type:
- Article
Social outcome in children treated by haematopoietic cell transplant for congenital immunodeficiency.
- Published in:
- Bone Marrow Transplantation, 2011, v. 46, n. 10, p. 1314, doi. 10.1038/bmt.2010.318
- By:
- Publication type:
- Article
Neuroprotective effect of activated 5'-adenosine monophosphate-activated protein kinase on cone system function during retinal inflammation.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Gene Therapy: Genetically correct?
- Published in:
- Nature Reviews Immunology, 2002, v. 2, n. 8, p. 545, doi. 10.1038/nri876
- By:
- Publication type:
- Article
Deficiency of Adenosine Deaminase 2 in Adult Siblings: Many Years of a Misdiagnosed Disease With Severe Consequences.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.01361
- By:
- Publication type:
- Article
First Occurrence of Plasmablastic Lymphoma in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Disease Patient and Review of the Literature.
- Published in:
- Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2018.00113
- By:
- Publication type:
- Article
Atypical Omenn Syndrome due to Adenosine Deaminase Deficiency.
- Published in:
- Case Reports in Immunology, 2012, p. 1, doi. 10.1155/2012/919241
- By:
- Publication type:
- Article
Two More Cell Infusions on Schedule for Gene Replacement Therapy Patient.
- Published in:
- JAMA: Journal of the American Medical Association, 1991, v. 265, n. 18, p. 2311, doi. 10.1001/jama.1991.03460180017007
- By:
- Publication type:
- Article
Gene Therapy Could Begin Next Month.
- Published in:
- JAMA: Journal of the American Medical Association, 1990, v. 264, n. 9, p. 1084, doi. 10.1001/jama.1990.03450090016004
- By:
- Publication type:
- Article
Next Step on Road to Possible Gene Therapy Expected in June, but Many Steps Remain.
- Published in:
- JAMA: Journal of the American Medical Association, 1990, v. 263, n. 16, p. 2150, doi. 10.1001/jama.1990.03440160012004
- Publication type:
- Article
ADA-SCID with 'WAZA-ARI' mutations that synergistically abolished ADA protein stability.
- Published in:
- British Journal of Haematology, 2011, v. 153, n. 5, p. 675, doi. 10.1111/j.1365-2141.2011.08640.x
- By:
- Publication type:
- Article
The evolving spectrum of ‘non-classical’ Diamond-Blackfan anaemia – a case of eADA positive pancytopenia in a young adult.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Severe combined immune deficiency in an adenosine deaminase-deficient patient.
- Published in:
- Allergy & Asthma Proceedings, 2006, v. 27, n. 2, p. 172
- By:
- Publication type:
- Article
Characteristic scapular and rib changes on chest radiographs of children with ADA-deficiency SCIDS in the first year of life.
- Published in:
- Pediatric Radiology, 2013, v. 43, n. 5, p. 589, doi. 10.1007/s00247-012-2564-2
- By:
- Publication type:
- Article
Highlights of the Latest Pediatric Rheumatology Research.
- Published in:
- MD Conference Express, 2014, v. 14, n. 17, p. 31, doi. 10.1177/155989771417020
- By:
- Publication type:
- Article
Epstein--Barr Virus--induced Lymphoblastoid Cell Lines from Patients with Primary Immunodeficiency Diseases.
- Published in:
- Scandinavian Journal of Immunology, 1980, v. 11, n. 2, p. 155, doi. 10.1111/j.1365-3083.1980.tb00221.x
- By:
- Publication type:
- Article
Clinical, imaging and genotypical features of three deceased and five surviving cases with ADA2 deficiency.
- Published in:
- Rheumatology International, 2018, v. 38, n. 1, p. 129, doi. 10.1007/s00296-017-3740-3
- By:
- Publication type:
- Article
Adenosine Deaminase Deficiency - More Than Just an immunodeficiency.
- Published in:
- Frontiers in Immunology, 2016, p. 1, doi. 10.3389/fimmu.2016.00314
- By:
- Publication type:
- Article
Gene Replacement Therapy Enters Second Year.
- Published in:
- JAMA: Journal of the American Medical Association, 1991, v. 266, n. 16, p. 2193, doi. 10.1001/jama.1991.03470160025008
- By:
- Publication type:
- Article
AMINOHYDROLASES ACTING ON ADENINE, ADENOSINE AND THEIR DERIVATIVES.
- Published in:
- Biomedical Papers of the Medical Faculty of Palacky University in Olomouc, 2007, v. 151, n. 1, p. 3, doi. 10.5507/bp.2007.001
- By:
- Publication type:
- Article
In utero gene therapy: The case for.
- Published in:
- Nature Medicine, 1999, v. 5, n. 3, p. 256, doi. 10.1038/6458
- By:
- Publication type:
- Article
Immune Regulation: What Immunodeficiency Disease Has Taught Us.
- Published in:
- Journal of Investigative Dermatology, 1985, v. 85, p. 149, doi. 10.1111/1523-1747.ep12275690
- By:
- Publication type:
- Article
Effect of Gold Nanoparticles Coated with Plasma Components on ADP-Induced Platelet Aggregation.
- Published in:
- Bulletin of Experimental Biology & Medicine, 2013, v. 155, n. 5, p. 685, doi. 10.1007/s10517-013-2226-x
- By:
- Publication type:
- Article
Effects of Vector Backbone and Pseudotype on Lentiviral Vector-mediated Gene Transfer: Studies in Infant ADA-Deficient Mice and Rhesus Monkeys.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 10, p. 1803, doi. 10.1038/mt.2014.88
- By:
- Publication type:
- Article
Preclinical Demonstration of Lentiviral Vector-mediated Correction of Immunological and Metabolic Abnormalities in Models of Adenosine Deaminase Deficiency.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 3, p. 607, doi. 10.1038/mt.2013.265
- By:
- Publication type:
- Article
Early Enzyme Replacement Therapy Improves Hearing and Immune Defects in Adenosine Deaminase Deficient-Mice.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.00416
- By:
- Publication type:
- Article
Abstracts for the 38th Human Genetics Society of Australasia Annual Scientific Meeting Adelaide, South Australia: August 3–6, 2014.
- Published in:
- 2014
- Publication type:
- Abstract
Extreme Thrombocytosis in Response to PEG-ADA: Early Therapeutic and Risk Indicator.
- Published in:
- Clinical Pediatrics, 2000, v. 39, n. 3, p. 183, doi. 10.1177/000992280003900309
- By:
- Publication type:
- Article
Treatment of Adenosine Deaminase Deficiency.
- Published in:
- BioDrugs, 1998, v. 9, n. 2, p. 87, doi. 10.2165/00063030-199809020-00001
- By:
- Publication type:
- Article
Progress in Genetic Therapy for Severe Combined Immunodeficiency Associated With Adenosine Deaminase Deficiency.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 4, p. 577, doi. 10.1038/mt.2009.57
- By:
- Publication type:
- Article
861. Recombinant Adeno-Associated Virus Vector Mediated Gene Therapy of Adenosine Deaminase Deficiency in a Mouse Model.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S331, doi. 10.1016/j.ymthe.2006.08.947
- By:
- Publication type:
- Article
In Vivo Transduction by Intravenous Injection of a Lentiviral Vector Expressing Human ADA into Neonatal ADA Gene Knockout Mice: A Novel Form of Enzyme Replacement Therapy for ADA Deficiency.
- Published in:
- Molecular Therapy, 2006, v. 13, n. 6, p. 1110, doi. 10.1016/j.ymthe.2006.02.013
- By:
- Publication type:
- Article
333. Preferential Targeting of Transcriptional Start Sites after Retroviral-Mediated T-Cell Gene Therapy for Adenosine Deaminase Deficiency
- Published in:
- 2005
- By:
- Publication type:
- Abstract
331. Lentivirus-Mediated Ex Vivo Gene Therapy in ADA-Deficient SCID Mice
- Published in:
- 2005
- By:
- Publication type:
- Abstract
37. A Novel Form of Enzyme Replacement Therapy for ADA-Deficiency: In Vivo Transduction by Neonatal Injection of Lentivirus Expressing ADA
- Published in:
- 2005
- By:
- Publication type:
- Abstract
Adipokines and central control in adenosine A1 receptor dependent glucose metabolism.
- Published in:
- Adipocyte, 2012, v. 1, n. 2, p. 108, doi. 10.4161/adip.19285
- By:
- Publication type:
- Article
Current strides in AAV-derived vectors and SIN channels further relieves the limitations of gene therapy.
- Published in:
- 2018
- By:
- Publication type:
- Abstract
Monogenic polyarteritis: the lesson of ADA2 deficiency.
- Published in:
- Pediatric Rheumatology, 2016, v. 14, p. 1, doi. 10.1186/s12969-016-0111-7
- By:
- Publication type:
- Article
Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment.
- Published in:
- Journal of Clinical Immunology, 2018, v. 38, n. 5, p. 569, doi. 10.1007/s10875-018-0525-8
- By:
- Publication type:
- Article
ADA Deficiency: Evaluation of the Clinical and Laboratory Features and the Outcome.
- Published in:
- Journal of Clinical Immunology, 2018, v. 38, n. 4, p. 484, doi. 10.1007/s10875-018-0496-9
- By:
- Publication type:
- Article
Novel Mutation in <italic>CECR1</italic> Leads to Deficiency of ADA2 with Associated Neutropenia.
- Published in:
- Journal of Clinical Immunology, 2018, v. 38, n. 3, p. 273, doi. 10.1007/s10875-018-0487-x
- By:
- Publication type:
- Article
Hematologic Manifestations of Deficiency of Adenosine Deaminase 2 (DADA2) and Response to Tumor Necrosis Factor Inhibition in DADA2-Associated Bone Marrow Failure.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Adenosine Deaminase (ADA)-Deficient Severe Combined Immune Deficiency (SCID): Molecular Pathogenesis and Clinical Manifestations.
- Published in:
- Journal of Clinical Immunology, 2017, v. 37, n. 7, p. 626, doi. 10.1007/s10875-017-0433-3
- By:
- Publication type:
- Article
Long-Term Outcome of Adenosine Deaminase-Deficient Patients-a Single-Center Experience.
- Published in:
- Journal of Clinical Immunology, 2017, v. 37, n. 6, p. 582, doi. 10.1007/s10875-017-0421-7
- By:
- Publication type:
- Article
Erratum to: Adenosine Deaminase Deficient Severe Combined Immunodeficiency Presenting as Atypical Haemolytic Uraemic Syndrome.
- Published in:
- 2016
- By:
- Publication type:
- Erratum
Deficiency of Adenosine Deaminase 2 Causes Antibody Deficiency.
- Published in:
- Journal of Clinical Immunology, 2016, v. 36, n. 3, p. 179, doi. 10.1007/s10875-016-0245-x
- By:
- Publication type:
- Article
Diagnosis, Treatment and Long-Term Follow Up of Patients with ADA Deficiency: a Single-Center Experience.
- Published in:
- Journal of Clinical Immunology, 2015, v. 35, n. 7, p. 624, doi. 10.1007/s10875-015-0191-z
- By:
- Publication type:
- Article
Outcomes in Two Japanese Adenosine Deaminase-Deficiency Patients Treated by Stem Cell Gene Therapy with No Cytoreductive Conditioning.
- Published in:
- Journal of Clinical Immunology, 2015, v. 35, n. 4, p. 384, doi. 10.1007/s10875-015-0157-1
- By:
- Publication type:
- Article